ArticleFrontiers in pharmacology2026

SOM3355: a unique pharmacological profile combining VMAT1 inhibition, VMAT2-mediated dopamine modulation, and β

Emily S Turilli-Ghisolfi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.